Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 09:42 am Unchanged | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | RTW Investments, LP | 2,463,601 12.130% | 0 (Unchanged) | Filing History |
| 2021-02-12 09:40 am Unchanged | 2020-12-31 | 13G | Stoke Therapeutics, Inc. STOK | RTW Investments, LP | 3,544,248 9.890% | 0 (Unchanged) | Filing History |
| 2021-02-12 09:39 am Purchase | 2020-12-31 | 13G | BrainsWay Ltd. BWAY | RTW Investments, LP | 2,206,948 9.920% | 290,096 (+15.13%) | Filing History |
| 2021-02-12 09:38 am Purchase | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | RTW Investments, LP | 1,512,673 9.310% | 256,816 (+20.45%) | Filing History |
| 2021-02-12 09:37 am Purchase | 2020-12-31 | 13G | BELLUS Health Inc. BLU | RTW Investments, LP | 5,189,862 6.620% | 348,870 (+7.21%) | Filing History |
| 2021-02-12 09:36 am Purchase | 2020-12-31 | 13G | Protagonist Therapeutics, Inc. PTGX | RTW Investments, LP | 3,650,069 8.670% | 1,190,081 (+48.38%) | Filing History |
| 2021-02-12 09:34 am Purchase | 2020-12-31 | 13G | PTC Therapeutics, Inc. PTCT | RTW Investments, LP | 4,221,836 6.190% | 389,356 (+10.16%) | Filing History |
| 2021-02-12 09:34 am Purchase | 2020-12-31 | 13G | Avadel Pharmaceuticals plc AVDL | RTW Investments, LP | 5,387,513 9.260% | 1,986,079 (+58.39%) | Filing History |
| 2021-02-12 09:32 am Purchase | 2020-12-31 | 13G | ProQR Therapeutics N.V. PRQR | RTW Investments, LP | 5,009,768 9.260% | 230,633 (+4.83%) | Filing History |
| 2021-02-12 09:31 am Purchase | 2020-12-31 | 13G | Athira Pharma, Inc. ATHA | RTW Investments, LP | 2,685,779 8.260% | 16,866 (+0.63%) | Filing History |
| 2021-02-12 09:30 am Purchase | 2020-12-31 | 13G | Oyster Point Pharma, Inc. OYST | RTW Investments, LP | 1,925,594 7.450% | 10,988 (+0.57%) | Filing History |
| 2021-02-12 09:28 am Unchanged | 2020-12-31 | 13G | Apyx Medical Corporation APYX | RTW Investments, LP | 3,391,279 9.890% | 0 (Unchanged) | Filing History |
| 2021-02-12 09:28 am Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RTW Investments, LP | 4,315,201 14.460% | 356,937 (+9.02%) | Filing History |
| 2021-02-12 09:26 am Sale | 2020-12-31 | 13G | La Jolla Pharmaceutical Company LJPC | RTW Investments, LP | 2,397,378 8.750% | -153,642 (-6.02%) | Filing History |
| 2021-02-12 09:25 am Sale | 2020-12-31 | 13G | Aptevo Therapeutics Inc. APVO | RTW Investments, LP | 177 6.960% | -1 (-0.61%) | Filing History |
| 2021-02-12 09:23 am Purchase | 2020-12-31 | 13G | Arbutus Biopharma Corporation ABUS | RTW Investments, LP | 5,978,355 7.050% | 311,601 (+5.50%) | Filing History |
| 2021-02-12 09:21 am Sale | 2020-12-31 | 13G | Agenus Inc. AGEN | RTW Investments, LP | 655,455 6.760% | -43,846 (-6.27%) | Filing History |
| 2021-02-12 09:17 am Purchase | 2020-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | RTW Investments, LP | 722,736 7.420% | 84,076 (+13.16%) | Filing History |
| 2021-02-04 12:36 pm Purchase | 2021-01-25 | 13G | iTeos Therapeutics, Inc. ITOS | RTW Investments, LP | 2,762,791 7.880% | 2,762,791 (New Position) | Filing History |
| 2021-01-22 11:12 am Purchase | 2021-01-12 | 13G | IDEAYA Biosciences, Inc. IDYA | RTW Investments, LP | 2,096,843 7.210% | 2,096,843 (New Position) | Filing History |